Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Placenta growth factor mediated gene regulation in sickle cell disease.

Kalra VK, Zhang S, Malik P, Tahara SM.

Blood Rev. 2018 Jan;32(1):61-70. doi: 10.1016/j.blre.2017.08.008. Epub 2017 Aug 16. Review.

2.

Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2.

Chen CL, Huang JY, Wang CH, Tahara SM, Zhou L, Kondo Y, Schechter J, Su L, Lai MM, Wakita T, Cosset FL, Jung JU, Machida K.

Nat Commun. 2017 Jan 9;8:13882. doi: 10.1038/ncomms13882.

3.

Activated Transcription Factor 3 in Association with Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression.

Li C, Zhou Y, Loberg A, Tahara SM, Malik P, Kalra VK.

Mol Cell Biol. 2016 Oct 28;36(22):2838-2854. doi: 10.1128/MCB.00345-16. Print 2016 Nov 15.

4.

NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.

Chen CL, Uthaya Kumar DB, Punj V, Xu J, Sher L, Tahara SM, Hess S, Machida K.

Cell Metab. 2016 Jan 12;23(1):206-19. doi: 10.1016/j.cmet.2015.12.004. Epub 2015 Dec 24.

5.
6.

Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.

Gonsalves CS, Li C, Mpollo MS, Pullarkat V, Malik P, Tahara SM, Kalra VK.

Biochem J. 2015 Jun 15;468(3):409-23. doi: 10.1042/BJ20141138. Epub 2015 Apr 16.

7.

MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.

Li C, Gonsalves CS, Eiymo Mwa Mpollo MS, Malik P, Tahara SM, Kalra VK.

Mol Cell Biol. 2015 Feb;35(3):514-28. doi: 10.1128/MCB.01199-14. Epub 2014 Nov 17.

8.

Peroxisome proliferator-activated receptor-α-mediated transcription of miR-199a2 attenuates endothelin-1 expression via hypoxia-inducible factor-1α.

Li C, Mpollo MS, Gonsalves CS, Tahara SM, Malik P, Kalra VK.

J Biol Chem. 2014 Dec 26;289(52):36031-47. doi: 10.1074/jbc.M114.600775. Epub 2014 Nov 11.

9.

Argonaute-2 promotes miR-18a entry in human brain endothelial cells.

Ferreira R, Santos T, Amar A, Gong A, Chen TC, Tahara SM, Giannotta SL, Hofman FM.

J Am Heart Assoc. 2014 May 16;3(3):e000968. doi: 10.1161/JAHA.114.000968.

10.

Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway.

Pullarkat V, Meng Z, Tahara SM, Johnson CS, Kalra VK.

Hemoglobin. 2014;38(3):188-95. doi: 10.3109/03630269.2014.898651. Epub 2014 Mar 26.

PMID:
24670032
11.

MicroRNA-18a improves human cerebral arteriovenous malformation endothelial cell function.

Ferreira R, Santos T, Amar A, Tahara SM, Chen TC, Giannotta SL, Hofman FM.

Stroke. 2014 Jan;45(1):293-7. doi: 10.1161/STROKEAHA.113.003578. Epub 2013 Nov 7.

PMID:
24203843
12.

Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.

Pham LK, Liang M, Adisetiyo HA, Liao CP, Cohen MB, Tahara SM, Frenkel B, Kasahara N, Roy-Burman P.

Endocr Relat Cancer. 2013 Nov 4;20(6):861-74. doi: 10.1530/ERC-13-0100. Print 2013 Dec.

13.
14.

Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm.

Wooderchak WL, Zang T, Zhou ZS, Acuña M, Tahara SM, Hevel JM.

Biochemistry. 2008 Sep 9;47(36):9456-66. doi: 10.1021/bi800984s. Epub 2008 Aug 13.

PMID:
18700728
15.

Reduced phagocytosis of colloidal carriers using soluble CD47.

Hsu YC, Acuña M, Tahara SM, Peng CA.

Pharm Res. 2003 Oct;20(10):1539-42.

PMID:
14620504
16.

New ways of initiating translation in eukaryotes.

Schneider R, Agol VI, Andino R, Bayard F, Cavener DR, Chappell SA, Chen JJ, Darlix JL, Dasgupta A, Donzé O, Duncan R, Elroy-Stein O, Farabaugh PJ, Filipowicz W, Gale M Jr, Gehrke L, Goldman E, Groner Y, Harford JB, Hatzglou M, He B, Hellen CU, Hentze MW, Hershey J, Hershey P, Hohn T, Holcik M, Hunter CP, Igarashi K, Jackson R, Jagus R, Jefferson LS, Joshi B, Kaempfer R, Katze M, Kaufman RJ, Kiledjian M, Kimball SR, Kimchi A, Kirkegaard K, Koromilas AE, Krug RM, Kruys V, Lamphear BJ, Lemon S, Lloyd RE, Maquat LE, Martinez-Salas E, Mathews MB, Mauro VP, Miyamoto S, Mohr I, Morris DR, Moss EG, Nakashima N, Palmenberg A, Parkin NT, Pe'ery T, Pelletier J, Peltz S, Pestova TV, Pilipenko EV, Prats AC, Racaniello V, Read GS, Rhoads RE, Richter JD, Rivera-Pomar R, Rouault T, Sachs A, Sarnow P, Scheper GC, Schiff L, Schoenberg DR, Semler BL, Siddiqui A, Skern T, Sonenberg N, Sossin W, Standart N, Tahara SM, Thomas AA, Toulmé JJ, Wilusz J, Wimmer E, Witherell G, Wormington M.

Mol Cell Biol. 2001 Dec;21(23):8238-46. No abstract available.

17.
18.

Mouse hepatitis virus nucleocapsid protein as a translational effector of viral mRNAs.

Tahara SM, Dietlin TA, Nelson GW, Stohlman SA, Manno DJ.

Adv Exp Med Biol. 1998;440:313-8.

PMID:
9782298
20.

Differential expression of the murine eukaryotic translation initiation factor isogenes eIF4A(I) and eIF4A(II) is dependent upon cellular growth status.

Williams-Hill DM, Duncan RF, Nielsen PJ, Tahara SM.

Arch Biochem Biophys. 1997 Feb 1;338(1):111-20.

PMID:
9015395
21.

Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis.

Stohlman SA, Hinton DR, Cua D, Dimacali E, Sensintaffar J, Hofman FM, Tahara SM, Yao Q.

J Virol. 1995 Sep;69(9):5898-903.

22.

Transcription and translation of proinflammatory cytokines following JHMV infection.

Stohlman SA, Yao Q, Bergmann CC, Tahara SM, Kyuwa S, Hinton DR.

Adv Exp Med Biol. 1995;380:173-8.

PMID:
8830475
23.

Modulation of cellular macromolecular synthesis by coronavirus: implication for pathogenesis.

Kyuwa S, Cohen M, Nelson G, Tahara SM, Stohlman SA.

J Virol. 1994 Oct;68(10):6815-9.

24.

Coronavirus translational regulation: leader affects mRNA efficiency.

Tahara SM, Dietlin TA, Bergmann CC, Nelson GW, Kyuwa S, Anthony RP, Stohlman SA.

Virology. 1994 Aug 1;202(2):621-30.

PMID:
8030227
25.

Expression of rat liver reduced glutathione transport in Xenopus laevis oocytes.

Fernández-Checa JC, Yi JR, Garcia-Ruiz C, Knezic Z, Tahara SM, Kaplowitz N.

J Biol Chem. 1993 Feb 5;268(4):2324-8.

26.

Diversity in the signals required for nuclear accumulation of U snRNPs and variety in the pathways of nuclear transport.

Fischer U, Darzynkiewicz E, Tahara SM, Dathan NA, Lührmann R, Mattaj IW.

J Cell Biol. 1991 May;113(4):705-14.

27.

Effect of eukaryotic initiation factor 4F on AUG selection in a bicistronic mRNA.

Tahara SM, Dietlin TA, Dever TE, Merrick WC, Worrilow LM.

J Biol Chem. 1991 Feb 25;266(6):3594-601.

29.

The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear targeting signal.

Hamm J, Darzynkiewicz E, Tahara SM, Mattaj IW.

Cell. 1990 Aug 10;62(3):569-77.

PMID:
2143105
30.

A spectroscopic study of the binding of N-7-substituted cap analogues to human protein synthesis initiation factor 4E.

Carberry SE, Darzynkiewicz E, Stepinski J, Tahara SM, Rhoads RE, Goss DJ.

Biochemistry. 1990 Apr 3;29(13):3337-41.

PMID:
2334695
31.

Inhibition of eukaryotic translation by nucleoside 5'-monophosphate analogues of mRNA 5'-cap: changes in N7 substituent affect analogue activity.

Darzynkiewicz E, Stepinski J, Ekiel I, Goyer C, Sonenberg N, Temeriusz A, Jin Y, Sijuwade T, Haber D, Tahara SM.

Biochemistry. 1989 May 30;28(11):4771-8.

PMID:
2548592
32.

Beta-globin mRNAs capped with m7G, m2.7(2)G or m2.2.7(3)G differ in intrinsic translation efficiency.

Darzynkiewicz E, Stepinski J, Ekiel I, Jin Y, Haber D, Sijuwade T, Tahara SM.

Nucleic Acids Res. 1988 Sep 26;16(18):8953-62.

35.

Monoclonal antibodies to a recombinant human leukocyte interferon (rIFN-alpha B).

Osheroff PL, Tahara SM, Chiang TR.

Clin Immunol Immunopathol. 1984 Feb;30(2):188-96.

PMID:
6692601
36.
37.

New initiation factor activity required for globin mRNA translation.

Grifo JA, Tahara SM, Morgan MA, Shatkin AJ, Merrick WC.

J Biol Chem. 1983 May 10;258(9):5804-10.

38.

Preparation, characterization, and properties of monoclonal antibodies against the lac carrier protein from Escherichia coli.

Carrasco N, Tahara SM, Patel L, Goldkorn T, Kaback HR.

Proc Natl Acad Sci U S A. 1982 Nov;79(22):6894-8.

39.

Production and characterization of a monoclonal antibody to the N protein of vesicular stomatitis virus (Indiana serotype).

De BP, Tahara SM, Banerjee AK.

Virology. 1982 Oct 30;122(2):510-4. No abstract available.

PMID:
6293185
41.

Characterization of eukaryotic initiation factor 4A, a protein involved in ATP-dependent binding of globin mRNA.

Grifo JA, Tahara SM, Leis JP, Morgan MA, Shatkin AJ, Merrick WC.

J Biol Chem. 1982 May 10;257(9):5246-52.

42.

5'-Terminal caps, cap-binding proteins and eukaryotic mRNA function.

Shatkin AJ, Darzynkiewicz E, Furuichi Y, Kroath H, Morgan MA, Tahara SM, Yamakawa M.

Biochem Soc Symp. 1982;47:129-43. Review. No abstract available.

PMID:
6765492
43.

Methyl esterification of m7G5'p reversibly blocks its activity as an analog of eukaryotic mRNA 5'-caps.

Darzynkiewicz E, Antosiewicz J, Ekiel I, Morgan MA, Tahara SM, Shatkin AJ.

J Mol Biol. 1981 Dec 5;153(2):451-8. No abstract available.

PMID:
7338917
44.
46.

Isolation of protein kinases from reticulocytes and phosphorylation of initiation factors.

Hathaway GM, Lundak TS, Tahara SM, Traugh JA.

Methods Enzymol. 1979;60:495-511. No abstract available.

PMID:
459914
47.

Effect of hemin on site-specific phosphorylation of eukaryotic initiation factor 2.

Tahara SM, Traugh JA, Sharp SB, Lundak TS, Safer B, Merrick WC.

Proc Natl Acad Sci U S A. 1978 Feb;75(2):789-93.

48.

Factors involved in initiation of haemoglobin synthesis can be phosphorylated in vitro.

Traugh JA, Tahara SM, Sharp SB, Safer B, Merrick WC.

Nature. 1976 Sep 9;263(5573):163-5. No abstract available.

PMID:
184395

Supplemental Content

Loading ...
Support Center